Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Off the wall

I respectfully suggest that the confusion arose because of the posting of an internal USPTO code regarding a patent application being erroneously applied to an ex-parte re-examination.

I hope this finally clarifies and settles the matter.

 

 

Be well

Share
New Message
Please login to post a reply